Polypore (NYSE:PPO) reported adjusted EPS from continuing operations of $0.31 (down 14%), above the consensus estimate of $0.29. The $0.31 figure excludes $0.87 associated with the operations and gain on sale of the Microporous business, which was reported in discontinued operations. During the quarter, EPS were unfavorably affected by about $0.04-$0.05 due to a higher-than-expected…
Sturm, Ruger & Company (NYSE:RGR) is lower in after hours trading after the company reported mixed financial results for Q4 and declared a quarterly dividend of $0.54 per share. Shares are down 4.91% at $65.01, with a 52-week range of $44.76 – $85.93. The firearms company reported Q4 earnings of $1.33 per share, compared with…
Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) are up 17.3%, positioning for a new 52-week high of $40.99 if the gains should hold into Wednesday. The stock just came off an evening-session halt after the company said it received FDA marketing approval for MONOVISC, a single injection supplement to synovial fluid of the osteoarthritic joint, used…
Pan American Silver (NASDAQ:PAAS) shares were down more than 3% Tuesday after the stock was downgraded to Sell from Neutral at Goldman Sachs, which lowered its price target to $10 from $15.22. PAAS was trading in a 52-week range of $14.66 to $15.04. Novo Nordisk (NYSE:NVO) shares were up about 5% after Bank of America…
After the markets closed on Monday, February 24, PRGX (NASDAQ:PRGX) reported fourth-quarter results that we believe are better than they appear at first blush. The headline results show a revenue shortfall of about $3 million relative to the consensus and a GAAP loss per share of $0.22, which are far below the consensus of about…
Chart Industries’ (NASDAQ:GTLS) overall fourth quarter 2013 EPS and awards were mostly in line with expectations; however, we believe this will be overshadowed by lower-than-expected 2014 EPS guidance ($3.10-$3.50 versus consensus $3.67) and more subdued market commentary regarding near-term growth prospects. There was already a somewhat downward bias to 2014 consensus EPS, the more cautious…
Tech Analysis & Market News